Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.
Latest News
-
Holding(s) in Company
24 March 2025 -
Placing to raise approximately £1.17 million
18 March 2025 -
Contract Win
27 February 2025
Investor Alert
Sign up for Investor Alerts »